Nanoparticles Enhance Lung Surfactant Distribution

Investigators at Purdue University have made significant advancements in nanotechnology by developing a novel delivery system for lung surfactant therapy. The research, published in Molecular Pharmaceutics, explores the impact of nanoparticle concentration and the addition of polyethylene glycol (PEG) on the distribution of polymer lung surfactant solutions in mouse lungs. The findings suggest that the addition of PEG significantly improves the spreading of the surfactant solution, particularly at higher concentrations.

Key Takeaways:

  • The efficacy of surfactant replacement therapy (SRT) depends on the effective delivery of active ingredients to the target site in the lungs.
  • Polymer lung surfactant (PLS) nanoparticles were used to examine the impact of PLS concentration on distribution and spreading in mouse lungs.
  • Three-dimensional tomographic analysis revealed significant concentration-dependent differences in PLS distribution, with lower concentrations exhibiting greater spreading.
  • The addition of a low-molecular-weight PEG to the PLS solution significantly improved spreading, particularly at higher concentrations.
  • This PEG-based enhancement strategy may also improve the delivery of commercial phospholipid-based LS formulations.
  • This research has been peer-reviewed and published in Molecular Pharmaceutics.

Statistics:

  • 60 mg/mL and 6.0 mg/mL PLS concentrations exhibited significant concentration-dependent differences in PLS distribution.
  • 0.1 mg/mL and 1.0 mg/mL PEG was added to the PLS solution to enhance spreading.
  • 3D tomographic analysis revealed a notable increase in lung pixel intensity (gray value) in mice receiving the lowest PLS concentration.
  • 80 mL and 4 mL/kg body weight PLS solutions were instilled into acid-injured mouse lungs for quantitative analysis.

Sources:

  • Molecular Pharmaceutics. "Intrapulmonary Spreading of Pharyngeally Instilled Liquids: Impact of Nanoparticle Concentration and PEG Lubrication in Polymer Lung Surfactant Solutions."
  • Amer Chemical Soc. "1155 16TH St, NW, Washington, DC 20036, USA."
  • Purdue University. "Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana 47907, United States."
  • Daniel J. Fesenmeier, Taesuk Jun, Sandra E. Torregrosa-Allen, Xinzhe Jin, Sangyoon Kim, Hye Jin Oh, Seon Yeop Jung, Bennett D. Elzey, Seyoung Kim, and You-Yeon Won. "Intrapulmonary Spreading of Pharyngeally Instilled Liquids: Impact of Nanoparticle Concentration and PEG Lubrication in Polymer Lung Surfactant Solutions." Molecular Pharmaceutics, 2025.